In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exogen Inc.

Division of Smith & Nephew PLC
ortho.smith-nephew.com

Latest From Exogen Inc.

When the Body Alone Can't Build Bone

Orthobiologics are now on the horizon, driving suppliers to increase R&D spending. The goal is to develop high-margin products that will actively promote bone formation. Has the slow progress to commercialization of the first two products--bone morphogenic proteins developed by the collaborations of Stryker Corp/Creative Biomolecules and Genetics Institute/Sofamor Danek--helped prime the market to accept a new technology? Or has the perception of delay dampened enthusiasm and scared off some of the big orthopedics players?
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Smith & Nephew PLC
  • Senior Management
  • Patrick A McBrayer, Pres. & CEO
    Richard H Reisner, VP, CFO
    John P Ryaby, Chmn. & VP, R&D
    Roger J Talish, VP, CTO
    David M Brintzinghoffer, VP, Operations
  • Contact Info
  • Exogen Inc.
    Phone: (908) 981-0990
    10 Constitution Ave.
    P.O. Box 6860 Piscataway, NJ 08855
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register